{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:02:49Z","timestamp":1789581769746,"version":"build-2803163510"},"reference-count":56,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Ment Health"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Auditory verbal hallucinations (AVH) are among the most disabling symptoms of schizophrenia and often persist despite treatment. Virtual reality\u2013assisted therapies (VRTs) are a new generation of relational interventions for AVH, but comparative evidence against active interventions is currently lacking.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to assess whether VRT (9 sessions) is superior to a short course of cognitive behavioral therapy (CBT) targeting AVH (9 sessions) in reducing AVH in individuals with treatment-resistant schizophrenia.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this assessor-blind, parallel-group randomized controlled trial conducted from 2019 to 2026 at an academic center in Montreal (Canada), adults with schizophrenia or schizoaffective disorder and persistent AVH were either referred by their health care team or self-referred. A total of 136 participants were randomly assigned 1:1 to VRT or CBT, stratified by sex and clozapine use status. Both 9-session interventions targeted maladaptive beliefs and relationships with voices and were administered by trained psychotherapists. The predetermined primary outcome was the evolution of AVH severity over time, measured at baseline, post treatment, and 3 months post therapy using the auditory hallucination subscale of the Psychotic Symptoms Rating Scale. Secondary outcomes notably included the general psychotic symptomatology measured using the Positive and Negative Syndrome Scale. Linear mixed-effects models were used to assess time-by-treatment interactions. Psychotherapy sessions and assessments were conducted primarily in person, with CBT being occasionally delivered via videoconferencing during the COVID-19 pandemic.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Participants had a mean age of 40.3 (SD 12.8) years, 63.2% (86\/136) were male, and 56.6% (77\/136) received clozapine. Intention-to-treat analyses (VRT, n=67; CBT, n=69) showed a significant time-by-treatment interaction favoring VRT (\n P<\/jats:italic>\n =.013) with a moderate effect size at 3 months post therapy (Cohen\n d<\/jats:italic>\n =0.614). Both therapies showed significant within-group improvements in the primary outcome, with large effect sizes for VRT (Cohen\n d<\/jats:italic>\n =0.81 post therapy and Cohen\n d<\/jats:italic>\n =1.17 at 3 months) and moderate for CBT (Cohen\n d<\/jats:italic>\n =0.58 post therapy and Cohen\n d<\/jats:italic>\n =0.39 at 3 months). While there were no between-group differences for secondary outcomes, within-group improvements were observed in psychotic symptoms, emotional regulation, and voice acceptance for both therapies, and VRT also reduced maladaptive beliefs about voices and improved self-esteem.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n VRT outperformed a targeted short course of CBT in reducing persistent AVH for up to 3 months after the intervention in a North American population with treatment-resistant schizophrenia. Improvements were also seen in some secondary outcomes, such as general psychotic symptomatology, and those were similar for both interventions. Overall, these findings support the value of VRT as a personalized and clinically effective intervention.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/106791","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:35:07Z","timestamp":1788186907000},"page":"e106791-e106791","source":"Crossref","is-referenced-by-count":0,"title":["Virtual Reality\u2013Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial"],"prefix":"10.2196","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-8055","authenticated-orcid":false,"given":"M\u00e9lissa","family":"Beaudoin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-378X","authenticated-orcid":false,"given":"St\u00e9phane","family":"Potvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-7217","authenticated-orcid":false,"given":"Sabrina","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8507-6412","authenticated-orcid":false,"given":"Charles-\u00c9douard","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-7511","authenticated-orcid":false,"given":"Frederick","family":"Aardema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Abdel-Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"De Benedictis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3235-8547","authenticated-orcid":false,"given":"Olivier","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0680-1359","authenticated-orcid":false,"given":"Pierre","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-2100","authenticated-orcid":false,"given":"Emmanuel","family":"Stip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-0163","authenticated-orcid":false,"given":"Alexandra","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsada","family":"Phraxayavong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-0064","authenticated-orcid":false,"given":"Alexandre","family":"Dumais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13696998.2022.2157596","article-title":"Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries","volume":"26","author":"Kotzeva","journal-title":"J Med Econ"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1176\/appi.focus.18402","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"18","author":"Keepers","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","journal-title":"Br J Psychiatry"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2025.10421","article-title":"Examining the safety profile of clozapine versus other antipsychotics: systematic review and meta-analysis","author":"Pinioti","journal-title":"Br J Psychiatry"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00406-019-01053-6","article-title":"Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study","volume":"270","author":"Shah","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41380-025-03255-y","article-title":"Non-clozapine interventions in treatment-resistant schizophrenia: a systematic review and meta-analysis","volume":"31","author":"Carr","journal-title":"Mol Psychiatry"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/schbul\/sbaa060","article-title":"Clozapine combination and augmentation strategies in patients with schizophrenia\u2014recommendations from an international expert survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group","volume":"46","author":"Wagner","journal-title":"Schizophr Bull"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.eurpsy.2016.10.011","article-title":"On the interconnectedness and prognostic value of visual and auditory hallucinations in first-episode psychosis","volume":"41","author":"Clark","journal-title":"Eur Psychiatr"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.10115","article-title":"The effectiveness of non-pharmacological treatments for auditory verbal hallucinations in schizophrenia spectrum disorders: a systematic review and meta-analysis","volume":"68","author":"Cobandag","journal-title":"Eur Psychiatr"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102392","article-title":"Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: an umbrella review of meta-analyses of randomised controlled trials","volume":"67","author":"Berendsen","journal-title":"EClinicalMedicine"},{"issue":"8","key":"R11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S2215-0366(18)30184-6","article-title":"Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial","volume":"5","author":"Morrison","journal-title":"Lancet Psychiatry"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00210","article-title":"Treatment-resistant to antipsychotics: a resistance to everything? Psychotherapy in treatment-resistant schizophrenia and nonaffective psychosis: a 25-year systematic review and exploratory meta-analysis","volume":"10","author":"Polese","journal-title":"Front Psychiatry"},{"issue":"11","key":"R13","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1017\/S003329172200143X","article-title":"A systematic review of relational-based therapies for the treatment of auditory hallucinations in patients with psychotic disorders","volume":"52","author":"Dellazizzo","journal-title":"Psychol Med"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaf142","article-title":"Relational therapies for people who hear voices: operationalisation and current status of an emergent group of psychological therapies","volume":"52","author":"Thomas","journal-title":"Schizophr Bull"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2215-0366(17)30427-3","article-title":"AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial","volume":"5","author":"Craig","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00139-2","article-title":"One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia","volume":"7","author":"Dellazizzo","journal-title":"NPJ Schizophr"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.02.031","article-title":"Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial","volume":"197","author":"Percie du Sert","journal-title":"Schizophr Res"},{"issue":"12","key":"R18","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1038\/s41591-024-03252-8","article-title":"Digital AVATAR therapy for distressing voices in psychosis: the phase 2\/3 AVATAR2 trial","volume":"30","author":"Garety","journal-title":"Nat Med"},{"issue":"6","key":"R19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1192\/bjp.bp.112.124883","article-title":"Computer-assisted therapy for medication-resistant auditory hallucinations: proof-of-concept study","volume":"202","author":"Leff","journal-title":"Br J Psychiatry"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.04.027","article-title":"Visual P300 as a neurophysiological correlate of symptomatic improvement by a virtual reality-based computer AT system in patients with auditory verbal hallucinations: a pilot study","volume":"151","author":"Liang","journal-title":"J Psychiatr Res"},{"issue":"8","key":"R21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S2215-0366(25)00161-0","article-title":"Immersive virtual reality-assisted therapy targeting persistent auditory verbal hallucinations in patients diagnosed with schizophrenia spectrum disorders in Denmark: the Challenge assessor-masked, randomised clinical trial","volume":"12","author":"Smith","journal-title":"Lancet Psychiatry"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00555","article-title":"Change in the neural response to auditory deviance following cognitive therapy for hallucinations in patients with schizophrenia","volume":"11","author":"Knott","journal-title":"Front Psychiatry"},{"issue":"9","key":"R23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S2215-0366(25)00202-0","article-title":"Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany","volume":"12","author":"Plewnia","journal-title":"Lancet Psychiatry"},{"key":"R24","unstructured":"Randomize. URL: https:\/\/www.randomize.net [Accessed 07-09-2026]"},{"issue":"5","key":"R25","doi-asserted-by":"publisher","DOI":"10.5935\/MedicalExpress.2016.05.01","article-title":"Cognitive-behavioral therapy for schizophrenia: an overview on efficacy, recent trends and neurobiological findings","volume":"3","author":"Candida","journal-title":"Med Express"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sbac209","article-title":"Efficacy of remotely delivered evidence-based psychosocial treatments for schizophrenia-spectrum disorders: a series of systematic reviews and meta-analyses","volume":"49","author":"Best","journal-title":"Schizophr Bull"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/cpp.2594","article-title":"Live psychotherapy by video versus in-person: a meta-analysis of efficacy and its relationship to types and targets of treatment","volume":"28","author":"Fernandez","journal-title":"Clin Psychol Psychother"},{"issue":"2","key":"R28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/wps.21088","article-title":"Therapist-supported Internet-based cognitive behaviour therapy yields similar effects as face-to-face therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis","volume":"22","author":"Hedman-Lagerl\u00f6f","journal-title":"World Psychiatry"},{"issue":"12","key":"R29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/pcn.12931","article-title":"Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV)","volume":"73","author":"Os\u00f3rio","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1017\/s0033291799008661","article-title":"Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS)","volume":"29","author":"Haddock","journal-title":"Psychol Med"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","journal-title":"Schizophr Bull"},{"issue":"1-3","key":"R32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia","volume":"137","author":"Wallwork","journal-title":"Schizophr Res"},{"issue":"3","key":"R33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/bjp.177.3.229","article-title":"The revised Beliefs About Voices Questionnaire (BAVQ\u2013R)","volume":"177","author":"Chadwick","journal-title":"Br J Psychiatry"},{"issue":"6","key":"R34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jclp.20366","article-title":"The voices acceptance and action scale (VAAS): pilot data","volume":"63","author":"Shawyer","journal-title":"J Clin Psychol"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.07.029","article-title":"Construct validity and factor structure of the difficulties in Emotion Regulation Scale among adults with severe mental illness","volume":"58","author":"Fowler","journal-title":"J Psychiatr Res"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0163278709356187","article-title":"Psychometric properties of the Rosenberg Self-Esteem Scale: overall and across demographic groups living within the United States","volume":"33","author":"Sinclair","journal-title":"Eval Health Prof"},{"issue":"2","key":"R37","first-page":"321","volume":"29","author":"Endicott","journal-title":"Psychopharmacol Bull"},{"issue":"6","key":"R38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157503","article-title":"Negative effects of psychological treatments: an exploratory factor analysis of the negative effects questionnaire for monitoring and reporting adverse and unwanted events","volume":"11","author":"Rozental","journal-title":"PLoS One"},{"issue":"5","key":"R39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S1352465819000018","article-title":"The Negative Effects Questionnaire: psychometric properties of an instrument for assessing negative effects in psychological treatments","volume":"47","author":"Rozental","journal-title":"Behav Cogn Psychother"},{"issue":"3","key":"R40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry","volume":"61","author":"Gueorguieva","journal-title":"Arch Gen Psychiatry"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.4097\/kja.25877","article-title":"Linear mixed-effects models for analysis of longitudinal repeated measures: a conceptual framework for clinical researchers","author":"Kim","journal-title":"Korean J Anesthesiol"},{"issue":"4","key":"R42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","journal-title":"Ann Statist"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1192\/bjp.bp.112.116285","article-title":"Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias","volume":"204","author":"Jauhar","journal-title":"Br J Psychiatry"},{"issue":"1","key":"R44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","journal-title":"J Exp Psychol Gen"},{"key":"R45","unstructured":"Lenth R . emmeans: estimated marginal means, aka least-squares means. R package version 1.8. 5; 2023. URL: https:\/\/CRAN.R-project.org\/package=emmeans [Accessed 10-01-2026]"},{"key":"R46","unstructured":"IBM SPSS Statistics for Windows (version 31.0). IBM Corp; 2021. URL: https:\/\/www.ibm.com\/support\/pages\/downloading-ibm-spss-statistics-31 [Accessed 07-01-2026]"},{"key":"R47","unstructured":"R Core Team. R: a language and environment for statistical computing. Foundation for Statistical Computing; 2025. URL: https:\/\/www.R-project.org\/ [Accessed 08-09-2026]"},{"issue":"3","key":"R48","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2026.11014","article-title":"Audio Visual Assisted Therapy Aid for Refractory Auditory Hallucinations (AVATAR) therapy for voice hearers: systematic review and meta-analysis","volume":"12","author":"Opper","journal-title":"BJPsych Open"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291726104127","article-title":"AVATAR versus cognitive-behavioral therapy for medication-resistant auditory hallucination: a systematic review and network meta-analysis","volume":"56","author":"Hsu","journal-title":"Psychol Med"},{"issue":"3","key":"R50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","journal-title":"AJP"},{"issue":"3","key":"R51","doi-asserted-by":"publisher","DOI":"10.3390\/reports8030113","article-title":"Reattribution of auditory hallucinations throughout avatar therapy: a case series","volume":"8","author":"Gigu\u00e8re","journal-title":"Reports (MDPI)"},{"issue":"2","key":"R52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/17522439.2013.773457","article-title":"Avatar therapy for persecutory auditory hallucinations: what is it and how does it work?","volume":"6","author":"Leff","journal-title":"Psychosis"},{"issue":"5","key":"R53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S2215-0366(25)00031-8","article-title":"INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia","volume":"12","author":"McCutcheon","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"R54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2215-0366(24)00136-6","article-title":"Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis","volume":"11","author":"Salahuddin","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"R55","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1176\/appi.focus.25023026","article-title":"Efficacy and moderators of cognitive behavioural therapy for psychosis versus other psychological interventions: an individual-participant data meta-analysis","volume":"23","author":"Turner","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2016.05.004","article-title":"What is the minimal dose of cognitive behavior therapy for psychosis? An approximation using repeated assessments over 45 sessions","volume":"38","author":"Lincoln","journal-title":"Eur Psychiatry"}],"container-title":["JMIR Mental Health"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:22:59Z","timestamp":1789579379000},"score":1,"resource":{"primary":{"URL":"https:\/\/mental.jmir.org\/2026\/1\/e106791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":56,"URL":"https:\/\/doi.org\/10.2196\/106791","relation":{},"ISSN":["2368-7959"],"issn-type":[{"value":"2368-7959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"v13i1e106791"}}